Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects. These drugs slow digestion to help control appetite, which can lead to changes in stool ...

If you happen to sit next to Mima Mendoza on a train or stand behind her in a checkout line, you might get an earful about the benefits of lifting weights. “I’ve become like the person at the train ...

Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond injections. Like the injections, GLP-1 pills can help regulate your appetite, ...

Of all the millions of people who have tried weight-loss drugs such as Wegovy and Zepbound, nearly one in four people don’t respond to treatment. They lose little weight, or none at all, and see few ...

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...

People who stop taking popular weight-loss and diabetes medications may lose out on any heart health benefits the medications provided. GLP-1 receptor agonists — such as semaglutide (Ozempic and ...

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...

While Lilly’s position in the obesity market and wider GLP-1 space has remained largely unshakeable in recent months, a crack in the company’s armor may be forming, according to at least one analyst.

GLP-1 receptor agonists have seen far greater traction in the US than in Europe. Uptake of the drugs is already at around 12% in the US, according to the Dutch bank ING. However, in the EU and UK, ...

Are GLP-1 weight loss drugs like Ozempic the miracle many have waited for, or are used guinea pigs in an experiment they’ll regret in a decade? That’s the central question of a discussion Wednesday on ...

Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...